Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.001 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.06 |